Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Respir Res ; 21(1): 30, 2020 Jan 28.
Article in English | MEDLINE | ID: mdl-31992280

ABSTRACT

BACKGROUND: Alveolar macrophages are professional phagocytes that remove microbial pathogens inhaled into the lung. The phagocytic ability is compromised in chronic obstructive pulmonary disease (COPD). However, the molecular mechanisms underlying this defect in phagocytosis are not clearly defined. MATERIALS AND METHODS: Cell suspensions were collected from lung tissues of patients undergoing lung resection. Alveolar macrophages were detected as FSChi/ SSChi/CD45+/CD206+ cells in the isolated cell suspension by flow-cytometry. The cell surface expression of plasma membrane-bound phagocytic receptors (Fcγ receptor I (FcγRI), a complement receptor CD11b, macrophage scavenger receptor-1 (MSR-1), CD36 and Siglec-1) was determined on the alveolar macrophages. Correlations between the expression levels of the phagocytic receptors and disease severity were analysed. Phagocytosis of fluorescence-tagged bacteria by human alveolar macrophages was evaluated. RESULTS: The flow-cytometry analyses revealed that FcγRI, CD11b, MSR-1 and Siglec-1, but not CD36, were expressed on human alveolar macrophages. Among these receptors, Siglec-1 expression was significantly decreased on alveolar macrophages in COPD ex-smokers (n = 11), compared to control never-smokers (n = 11) or control ex-smokers (n = 9). The Siglec-1 expression on alveolar macrophages was significantly correlated with lung function (forced expiratory volume in 1 s) and with the severity of emphysema. Treatment of human alveolar macrophages with an anti-Siglec1 blocking antibody decreased phagocytosis of non-typeable Haemophilus influenzae (NTHi). CONCLUSION: Our findings demonstrated reduced expression of Siglec-1 on alveolar macrophages in COPD, which is involved in engulfment of NTHi.


Subject(s)
Macrophages, Alveolar/metabolism , Phagocytes/metabolism , Pulmonary Disease, Chronic Obstructive/metabolism , Sialic Acid Binding Ig-like Lectin 1/biosynthesis , Aged , Cells, Cultured , Female , Flow Cytometry/methods , Gene Expression , Humans , Macrophages, Alveolar/pathology , Male , Middle Aged , Phagocytes/pathology , Phagocytosis/physiology , Pulmonary Disease, Chronic Obstructive/genetics , Pulmonary Disease, Chronic Obstructive/pathology , Respiratory Function Tests/methods , Sialic Acid Binding Ig-like Lectin 1/genetics
2.
Respir Investig ; 54(3): 211-5, 2016 May.
Article in English | MEDLINE | ID: mdl-27108018

ABSTRACT

Endobronchial aspergilloma is a rare and unusual presentation of lung aspergilloma; the natural history for such rare diseases is poorly understood. This report presents two cases of endobronchial aspergilloma complicated by primary and metastatic lung cancer, and summarizes previous reports that suggest that an endobronchial lung cancer lesion may promote the colonialization and growth of Aspergillus species in the bronchus. Therefore, if endobronchial aspergilloma is found, the complication of primary or metastatic endobronchial lung cancer should be carefully considered.


Subject(s)
Lung Neoplasms/complications , Pulmonary Aspergillosis/etiology , Aged , Aged, 80 and over , Aspergillus/growth & development , Bronchi/diagnostic imaging , Bronchi/microbiology , Bronchi/pathology , Humans , Lung Neoplasms/diagnosis , Male , Pulmonary Aspergillosis/diagnosis , Pulmonary Aspergillosis/microbiology , Pulmonary Aspergillosis/pathology , Radiography, Thoracic , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...